ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,450Medicare Part D Prescriptions Filled, Including Refills

Rank: 82 out of 198

$534K Total Retail Price of All Prescriptions

Rank: 50 out of 198

268 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
21% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 268 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

20% of this provider’s 268 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 6,736 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$72 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
SIMVASTATIN 373 334 1 2
HYDROCODONE-ACETAMINOPHEN 273 243 S3 2 8
LEVOTHYROXINE SODIUM 225 199 3 1
AMLODIPINE BESYLATE 215 215 4 4
SYNTHROID 208 196 5 36
OMEPRAZOLE 208 195 5 3
FUROSEMIDE 202 179 7 5
ALENDRONATE SODIUM 174 163 8 21
BENAZEPRIL HCL 163 162 9 45
ATENOLOL 149 129 10 17
ZOLPIDEM TARTRATE 139 121 11 22
GABAPENTIN 116 109 12 14
ATORVASTATIN CALCIUM 112 93 13 12
FENOFIBRATE 99 89 14 61
METFORMIN HCL 97 96 15 13
TRAMADOL HCL 87 81 16 15
LISINOPRIL 84 83 17 6
POTASSIUM CHLORIDE 82 77 18 9
WARFARIN SODIUM 82 79 18 7
PRAVASTATIN SODIUM 82 82 18 19
DONEPEZIL HCL 74 74 21 28
METOPROLOL SUCCINATE 72 70 22 11
CLONIDINE HCL 70 70 23 52
PANTOPRAZOLE SODIUM 69 54 24 31
METFORMIN HCL ER 68 67 25 64
CRESTOR 62 57 26 26
JANUVIA 58 45 27 86
SERTRALINE HCL 56 55 28 25
POLYETHYLENE GLYCOL 3350 53 53 29 41
HYDROCHLOROTHIAZIDE 52 45 30 16
CELEBREX 52 48 30 59
BENICAR HCT 51 50 32 175
FLUOXETINE HCL 50 50 33 78
CYCLOBENZAPRINE HCL 50 29 R 33 67
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 29, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.